Toxoplasma gondii requires its plant-like heme biosynthesis pathway for infection
Amy Bergmann,Katherine Floyd,Melanie Key,Carly Dameron,Kerrick C. Rees,L. Brock Thornton,Daniel C. Whitehead,Iqbal Hamza,Zhicheng Dou
DOI: https://doi.org/10.1371/journal.ppat.1008499
IF: 7.464
2020-05-14
PLoS Pathogens
Abstract:Heme, an iron-containing organic ring, is essential for virtually all living organisms by serving as a prosthetic group in proteins that function in diverse cellular activities ranging from diatomic gas transport and sensing, to mitochondrial respiration, to detoxification. Cellular heme levels in microbial pathogens can be a composite of endogenous <em>de novo</em> synthesis or exogenous uptake of heme or heme synthesis intermediates. Intracellular pathogenic microbes switch routes for heme supply when heme availability fluctuates in their replicative environment throughout infection. Here, we show that <em>Toxoplasma gondii</em>, an obligate intracellular human pathogen, encodes a functional heme biosynthesis pathway. A chloroplast-derived organelle, termed apicoplast, is involved in heme production. Genetic and chemical manipulation revealed that <em>de novo</em> heme production is essential for <em>T</em>. <em>gondii</em> intracellular growth and pathogenesis. Surprisingly, the herbicide oxadiazon significantly impaired <em>Toxoplasma</em> growth, consistent with phylogenetic analyses that show <em>T</em>. <em>gondii</em> protoporphyrinogen oxidase is more closely related to plants than mammals. This inhibition can be enhanced by 15- to 25-fold with two oxadiazon derivatives, lending therapeutic proof that <em>Toxoplasma</em> heme biosynthesis is a druggable target. As <em>T</em>. <em>gondii</em> has been used to model other apicomplexan parasites, our study underscores the utility of targeting heme biosynthesis in other pathogenic apicomplexans, such as <em>Plasmodium spp</em>., <em>Cystoisospora</em>, <em>Eimeria</em>, <em>Neospora</em>, and <em>Sarcocystis</em>.<em>Toxoplasma gondii</em> infects essentially all warm-blooded animals due to its broad species and tissue tropism. Almost one-third of the human population carry <em>Toxoplasma</em> infection, which can cause severe morbidity and mortality in immunocompromised individuals. The current antibiotics against <em>Toxoplasma</em> trigger strong side effects in some groups of patients and have limited efficacy on congenital toxoplasmosis. Thus, an urgent need for novel therapeutics exist. Here, we show that <em>Toxoplasma gondii</em> actively produces heme, a key nutrient for many subcellular activities, via its plant-like heme biosynthesis pathway for intracellular growth and acute virulence. We found that several herbicidal heme biosynthesis inhibitors and their derivatives show inhibitory effects against intracellular <em>Toxoplasma</em> growth. Our findings provide evidence that disrupting heme production in <em>Toxoplasma</em> could be an effective therapeutic strategy to control infection.
microbiology,virology,parasitology